Simple Summary The prostate-specific membrane antigen (PSMA) protein present in most
prostate cancer cells has emerged as a promising target for the imaging and treatment of …

Molecular imaging and therapy is a rapidly evolving field in research and clinical medicine.
The use of the exciting and attractive properties of radioisotopes for imaging and therapy …

Prostate cancer is the most common cancer to affect men in the United States and the
second most common cancer in men worldwide. Prostate-specific membrane antigen …

Background: Prostate cancer (PCa) is the most common sex-related malignancy with high
mortality in men worldwide. Prostate-specific membrane antigen (PSMA) is overexpressed …

As described in more detail in other contributions in this issue of Seminars in Nuclear
Medicine, prostate-specific membrane antigen (PSMA) has become one of the most …

PSMA targeting antibodies are very promising for further clinical investigation and continue
to be a momentous research area, for both imaging and therapeutic settings. Although some …

Prostate cancer is the most common non-cutaneous malignancy affecting men in the US,
leading to significant morbidity and mortality. While significant therapeutic advances have …

Molecular changes in prostate cancer lead to increased expression of prostate-specific
membrane antigen (PSMA), which is a suitable target for imaging and therapy using …

Despite significant research activities and subsequent progress made in the fight against
cancer over the last few decades, prostate cancer remains a major health-related problem …

Simple Summary One of the most frequently diagnosed cancer in men is adenocarcinoma of
the prostate. Once the disease is metastatic, only very limited treatment options are …